Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Omega Healthcare Investors Inc    OHI

OMEGA HEALTHCARE INVESTORS INC (OHI)
Mes dernières consult.
Most popular
  Report  
Real-time Quote. Real-time Cboe BZX - 06/21 10:07:23 pm
31.84 USD   +1.24%
05/14OMEGA HEALTHCAR : Receives Approval to Transition Majority of Oriann..
BU
05/11OMEGA HEALTHCAR : Announces 2018 Investor Day Webcast
BU
05/08OMEGA HEALTHCAR : 1Q Earnings Snapshot
AQ
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles

Omega Healthcare Investors Inc : Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Omega Healthcare Investors, Inc. of Class Action Lawsuit and Upcoming Deadline - OHI

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/13/2018 | 02:26pm CEST

NEW YORK, NY / ACCESSWIRE / January 13, 2018 / Pomerantz LLP announces that a class action lawsuit has been filed against Omega Healthcare Investors, Inc. ("Omega" or the "Company") (NYSE: OHI) and certain of its officers. The class action, filed in United States District Court, for the Southern District of New York, and docketed under 17-cv-09024, is on behalf of a class consisting of investors who purchased or otherwise acquired Omega securities, seeking to recover compensable damages caused by defendants' violations of the Securities Exchange Act of 1934.

If you are a shareholder who purchased Omega securities between February 8, 2017, and October 31, 2017, both dates inclusive, you have until January 16, 2018, to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 9980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and amount of shares purchased.

[Click here to join this class action]

Omega is a self-administered real estate investment trust ("REIT") that invests in income producing healthcare facilities, including long-term care facilities located in the United States and the United Kingdom.

The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operational and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) financial and operating results of certain of the Company's operators were deteriorating; (ii) as a result, certain of the Company's operators were experiencing worsening liquidity issues that were significantly impacting the operators' ability to make timely rent payments; (iii) as a result, certain of the Company's direct financing leases were impaired and certain receivables were uncollectible; and (iv) as a result of the foregoing, Defendants' statements about Omega's business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis.

On July 26, 2017, after the market closed, the Company issued a press release entitled, "Omega Announces Second Quarter 2017 Financial Results; Increased Dividend Rate for 20th Consecutive Quarter."

On the next day, July 27, 2017, the Company held a conference call to discuss its second quarter results. On this news, the Company's stock price fell $1.35 per share, or 4%, to close at $32.10 per share on July 27, 2017, on unusually heavy trading volume.

The Pomerantz Firm, with offices in New York, Chicago, Florida, and Los Angeles, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.

SOURCE: Pomerantz LLP


© Accesswire 2018
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on OMEGA HEALTHCARE INVESTORS
06/11OMEGA HEALTHCARE INVESTORS INC : Change in Directors or Principal Officers, Subm..
AQ
05/14OMEGA HEALTHCARE INVESTORS : Receives Approval to Transition Majority of Orianna..
BU
05/11OMEGA HEALTHCARE INVESTORS : Announces 2018 Investor Day Webcast
BU
05/10OMEGA HEALTHCARE INVESTORS : Management's Discussion and Analysis of Financial C..
AQ
05/08OMEGA HEALTHCARE INVESTORS : 1Q Earnings Snapshot
AQ
05/07OMEGA HEALTHCARE INVESTORS INC : Results of Operations and Financial Condition, ..
AQ
05/07OMEGA HEALTHCARE INVESTORS : Announces First Quarter 2018 Financial Results; Con..
BU
05/01OMEGA HEALTHCARE INVESTORS INC : Financial Statements and Exhibits (form 8-K)
AQ
04/27OMEGA HEALTHCARE INVESTORS : Announces Release Date of First Quarter Earnings an..
BU
04/27OMEGA HEALTHCARE INVESTORS INC : Ex-dividend day for
FA
More news
News from SeekingAlpha
11:50aHEALTHCARE REITS : Back From The Dead? 
06/20Retail landlords lead rally in REITs 
06/18OMEGA : Exit Stage Left, Followed By All The Bears 
06/18DIVIDEND PORTFOLIO REVIEW : New Dividend Record 
06/16Will Rising Rates Derail This 11.95% Yielding REIT? 
Financials ($)
Sales 2018 871 M
EBIT 2018 507 M
Net income 2018 327 M
Debt 2018 4 524 M
Yield 2018 8,39%
P/E ratio 2018 20,11
P/E ratio 2019 19,32
EV / Sales 2018 12,2x
EV / Sales 2019 11,8x
Capitalization 6 149 M
Chart OMEGA HEALTHCARE INVESTORS
Duration : Period :
Omega Healthcare Investors Technical Analysis Chart | OHI | US6819361006 | 4-Traders
Technical analysis trends OMEGA HEALTHCARE INVESTORS
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 11
Average target price 29,2 $
Spread / Average Target -7,2%
EPS Revisions
Managers
NameTitle
Taylor C. Pickett Chief Executive Officer & Director
Craig R. Callen Chairman
Daniel J. Booth Chief Operating Officer
Robert O. Stephenson Chief Financial Officer & Treasurer
Bernard J. Korman Director
Sector and Competitors
1st jan.Capitalization (M$)
OMEGA HEALTHCARE INVESTORS INC14.20%6 149
WELLTOWER INC-8.45%21 281
VENTAS-8.77%19 138
HCP-6.06%11 275
HEALTHCARE TRUST OF AMERICA INC-13.08%5 236
MEDICAL PROPERTIES TRUST, INC.2.03%5 070